Loading
LOADING
Oral administration for GI tract research applications. The Sikiric work documented oral bioavailability sufficient for local GI mucosal effects. Systemic effects from oral are weaker than parenteral but the literature supports oral for gastrointestinal-targeted research.
| Compound | Dose | Frequency | Route |
|---|---|---|---|
| BPC-157 | 500mcg | 2x daily | Oral |
No comments yet. Start the thread.